Literature DB >> 25530119

TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.

Wenjing Yang1, Lin Xiao, Cui Li, Xiuyun Liu, Mingdong Liu, Qi Shao, Dan Wang, Aijun Huang, Cheng He.   

Abstract

Differentiation of oligodendrocyte precursor cells (OPCs) is a prerequisite for both developmental myelination and adult remyelination in the central nervous system. The molecular mechanisms underlying OPC differentiation remain largely unknown. Here, we show that the thirty-kDa HIV-1 Tat interacting protein (TIP30) is a negative regulator in oligodendrocyte development. The TIP30(-/-) mice displayed an increased myelin protein level at postnatal day 14 and 21. By using a primary OPC culture system, we demonstrated that overexpression of TIP30 dramatically inhibited the stage progression of differentiating OPCs, while knockdown of TIP30 enhanced the differentiation of oligodendroglial cells remarkably. Moreover, overexpression of TIP30 was found to sequester the transcription factor Olig1 in the cytoplasm and weaken its nuclear translocation due to the interaction between TIP30 and Olig1, whereas knockdown of TIP30 led to more Olig1 localized in the nucleus in the initiation stage during OPC differentiation. In the cuprizone-induced demyelination model, there was a dramatic increase in NG2-expressing cells with nuclear location of Olig1 in the corpus callosum during remyelination. In contrast, within chronic demyelinated lesions in multiple sclerosis, TIP30 was abnormally expressed in NG2-expressing cells, and few nuclear Olig1 was observed in these cells. Taken together, our findings suggest that TIP30 plays a negative regulatory role in oligodendroglial differentiation.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Olig1; TIP30; differentiation; multiple sclerosis; oligodendrocyte

Mesh:

Substances:

Year:  2014        PMID: 25530119     DOI: 10.1002/glia.22778

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  8 in total

1.  [New therapeutic strategies for remyelination in multiple sclerosis].

Authors:  D Kremer; H-P Hartung; M Stangel; P Küry
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

2.  P2X7 receptors and Fyn kinase mediate ATP-induced oligodendrocyte progenitor cell migration.

Authors:  Ji-Feng Feng; Xiao-Fei Gao; Ying-Yan Pu; Geoffrey Burnstock; Zhenghua Xiang; Cheng He
Journal:  Purinergic Signal       Date:  2015-06-23       Impact factor: 3.765

3.  Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.

Authors:  Yanqing Shi; Qi Shao; Zhenghao Li; Ginez A Gonzalez; Fengfeng Lu; Dan Wang; Yingyan Pu; Aijun Huang; Chao Zhao; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2018-02-03       Impact factor: 5.203

Review 4.  Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?

Authors:  Peter Göttle; Patrick Küry
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

5.  Karyopherin Alpha Proteins Regulate Oligodendrocyte Differentiation.

Authors:  Benjamin M Laitman; John N Mariani; Chi Zhang; Setsu Sawai; Gareth R John
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

6.  Pinocembrin Promotes OPC Differentiation and Remyelination via the mTOR Signaling Pathway.

Authors:  Qi Shao; Ming Zhao; Wenwen Pei; Yingyan Pu; Mingdong Liu; Weili Liu; Zhongwang Yu; Kefu Chen; Hong Liu; Benqiang Deng; Li Cao
Journal:  Neurosci Bull       Date:  2021-06-06       Impact factor: 5.271

7.  Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.

Authors:  Xiaoming Yao; Tao Su; A S Verkman
Journal:  Acta Neuropathol Commun       Date:  2016-04-26       Impact factor: 7.801

Review 8.  Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.

Authors:  Han Liu; Enquan Xu; Jianuo Liu; Huangui Xiong
Journal:  Brain Sci       Date:  2016-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.